From: Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor
Characteristics | Uremic toxin sources | Molecular weight | Dialysis modalities | Metabolic pathways and uremic toxin products |
---|---|---|---|---|
Protein-bound (Protein-bound ≥ 80%) | Exogenous (Gut-derived) | < 0.5 kDa | Low-flux HD; High-flux HD; High-flux HDF; Medium cutoff HDx; High cutoff HD; | Tryptophan metabolism (IS, KYN, IAA, KYNA [2]); Tyrosine metabolism (PCS [18]); Methionine metabolism (Homocysteine [173]); Maillard reaction (carboxymethyl lysine [174]) |
Water soluble (Protein-bound < 80%) | Exogenous and exogenous (Both gut-derived and endogenous metabolism) | < 0.5 kDa | Low-flux HD; High-flux HD; High-flux HDF; Medium cutoff HDx; High cutoff HD; | Choline, carnitine and betaine metabolism (TMAO [31]); Arginine methylation (asymmetric dimethylarginine, symmetric dimethylarginine [175]); Purine metabolism (uric acid [176]); Carbamylation (carbamylated compounds [177]) |
Endogenous (endogenous metabolism) | 0.5–15 kDa | High-flux HD; High-flux HDF; Medium cutoff HDx; High cutoff HD | Cytokine (IL-8); Structural protein (β2-microglobulin) | |
> 15–25 kDa | High-flux HDF; Medium cutoff HDx; High cutoff HD | Cytokines (TNF, IL-18, IL-10, IL-6, FGF-2); Hormone (prolactin); Structural proteins (kappa-FLC, myoglobin, sTNFR2, complement factor D); | ||
> 25–58 kDa | Medium cutoff HDx; High cutoff HD | Cytokines (pentatraxin-3, FGF-23, CX3CL1, CXCL12, IL-2); Structural proteins (sTNFR1, lambda-FLC, YKL-40); Maillard reaction (advanced glycosylation end products [178]) | ||
> 58 kDa | High cutoff HD | Modified albumin |